Brad D. Maxwell

2.3k total citations · 2 hit papers
34 papers, 1.6k citations indexed

About

Brad D. Maxwell is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Brad D. Maxwell has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Brad D. Maxwell's work include Pharmacogenetics and Drug Metabolism (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Brad D. Maxwell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Brad D. Maxwell collaborates with scholars based in United States, Germany and Sweden. Brad D. Maxwell's co-authors include Rita Maria Concetta Di Martino, Tracey Pirali, Phil S. Baran, Josep Cornellà, Lara R. Malins, Martin D. Eastgate, Shuhei Kawamura, Tian Qin, Chao Li and Jacob T. Edwards and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Brad D. Maxwell

30 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A general alkyl-alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents

2016 628 citations Tian Qin, Josep Cornellà et al. Science profile →
Deuterium in drug discovery: progress, opportunities and challenges

2023 299 citations Rita Maria Concetta Di Martino, Brad D. Maxwell et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brad D. Maxwell United States	11	894	328	249	212	190	34	1.6k
Samuel J. Bonacorsi United States	17	487 0.5×	181 0.6×	428 1.7×	90 0.4×	247 1.3×	72	1.7k
Joseph M. Luettgen United States	27	736 0.8×	96 0.3×	999 4.0×	47 0.2×	460 2.4×	72	2.5k
Nicole Langlois France	29	1.7k 1.9×	84 0.3×	232 0.9×	273 1.3×	899 4.7×	156	3.0k
He Huang China	34	2.7k 3.0×	315 1.0×	25 0.1×	447 2.1×	371 2.0×	76	3.4k
Shoji Eguchi Japan	30	2.9k 3.3×	317 1.0×	404 1.6×	166 0.8×	831 4.4×	374	4.3k
Norbert Hauel Germany	16	430 0.5×	79 0.2×	909 3.7×	29 0.1×	551 2.9×	31	2.1k
Charles G. Clark United States	15	1.9k 2.1×	90 0.3×	64 0.3×	208 1.0×	413 2.2×	29	2.2k
W. E. Barnette United States	20	796 0.9×	187 0.6×	117 0.5×	119 0.6×	303 1.6×	36	1.5k
Thomas Antonsson Sweden	12	257 0.3×	20 0.1×	328 1.3×	63 0.3×	176 0.9×	25	842
Michèle P. Bertrand France	33	3.1k 3.4×	202 0.6×	222 0.9×	361 1.7×	645 3.4×	172	4.1k

Countries citing papers authored by Brad D. Maxwell

Since Specialization

Citations

This map shows the geographic impact of Brad D. Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad D. Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad D. Maxwell more than expected).

Fields of papers citing papers by Brad D. Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad D. Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad D. Maxwell. The network helps show where Brad D. Maxwell may publish in the future.

Co-authorship network of co-authors of Brad D. Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Brad D. Maxwell. A scholar is included among the top collaborators of Brad D. Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad D. Maxwell. Brad D. Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maxwell, Brad D., et al.. (2026). Semi‐Reduction of Allenes to Access Deuterated Allylic Isotopomers, Isotopologs and Enantioisotopomers. Angewandte Chemie International Edition. 65(13). e25850–e25850.

Martino, Rita Maria Concetta Di, Brad D. Maxwell, & Tracey Pirali. (2023). Deuterium in drug discovery: progress, opportunities and challenges. Nature Reviews Drug Discovery. 22(7). 562–584. 299 indexed citations breakdown →

Czeskis, Boris A., Charles S. Elmore, Anthony R. Haight, et al.. (2019). Deuterated active pharmaceutical ingredients: A science‐based proposal for synthesis, analysis, and control. Part 1: Framing the problem. Journal of Labelled Compounds and Radiopharmaceuticals. 62(11). 690–694. 21 indexed citations

Maxwell, Brad D., et al.. (2016). The syntheses of [¹⁴C]BMS‐823778 for use in a human ADME clinical study and of [¹³CD₃¹³CD₂]BMT‐094817, a stable‐isotope labeled standard of a newly detected human metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. 59(6). 255–259. 3 indexed citations

Maxwell, Brad D., et al.. (2016). The syntheses of isotopically labelled CB‐1 antagonists for the treatment of obesity. Journal of Labelled Compounds and Radiopharmaceuticals. 59(14). 665–672. 6 indexed citations

Qin, Tian, Josep Cornellà, Chao Li, et al.. (2016). A general alkyl-alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents. Science. 352(6287). 801–805. 628 indexed citations breakdown →

Cao, Kai, Brad D. Maxwell, & Samuel J. Bonacorsi. (2014). The synthesis of ¹⁴C‐labeled N‐succinimidyl‐3‐maleimidopropionate, a linker molecule for PEGylated biologics. Journal of Labelled Compounds and Radiopharmaceuticals. 57(12). 667–669. 1 indexed citations

Maxwell, Brad D., Kai Cao, Samuel J. Bonacorsi, et al.. (2013). The synthesis of a carbon‐14 labeled pegylated Adnectin™ for placental transfer studies in guinea pigs. Journal of Labelled Compounds and Radiopharmaceuticals. 56(9-10). 492–494. 5 indexed citations

Maxwell, Brad D., et al.. (2012). An improved synthesis of [2‐¹⁴C]2, 5‐dichloropyrimidine. Journal of Labelled Compounds and Radiopharmaceuticals. 55(8). 300–302. 1 indexed citations

10.

Maxwell, Brad D., et al.. (2011). A novel synthesis of [2‐¹⁴C]2,5‐dichloropyrimidine. Journal of Labelled Compounds and Radiopharmaceuticals. 54(13). 813–815. 3 indexed citations

11.

Wang, Lifei, Kan He, Brad D. Maxwell, et al.. (2010). Tissue Distribution and Elimination of [14C]Apixaban in Rats. Drug Metabolism and Disposition. 39(2). 256–264. 48 indexed citations

12.

Wang, Lifei, Donglu Zhang, Nirmala Raghavan, et al.. (2009). In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies. Drug Metabolism and Disposition. 38(3). 448–458. 212 indexed citations

13.

Zhang, Donglu, Kan He, Nirmala Raghavan, et al.. (2009). Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans. Drug Metabolism and Disposition. 37(8). 1738–1748. 89 indexed citations

14.

Maxwell, Brad D., Samuel J. Bonacorsi, Leslie Leith, et al.. (2009). Synthesis of lead LFA‐1 antagonist [¹⁴C]spyrocyclic hydantoin. Journal of Labelled Compounds and Radiopharmaceuticals. 52(6). 236–242. 9 indexed citations

15.

Maxwell, Brad D., et al.. (2005). The ¹⁴C, ¹³C and ¹⁵N syntheses of MON 37500, a sulfonylurea wheat herbicide. Journal of Labelled Compounds and Radiopharmaceuticals. 48(6). 397–406. 14 indexed citations

16.

Maxwell, Brad D.. (2000). The radiolabeled syntheses of JV 485, a herbicide candidate for winter wheat. Journal of Labelled Compounds and Radiopharmaceuticals. 43(7). 645–654. 12 indexed citations

17.

Maxwell, Brad D., et al.. (1988). Organic photochemistry. 74. Concerning the reported photosolvolysis of 4-chloro-2-butanone in alcoholic media. The Journal of Organic Chemistry. 53(1). 219–221. 1 indexed citations

18.

Maxwell, Brad D., et al.. (1987). Radiationless decay in substituted alkylbenzenes in solution. Chemical Physics Letters. 139(5). 475–478. 1 indexed citations

19.

Morrison, Harry, et al.. (1986). Organic photochemistry. 68. Photochemistry of polyfunctional molecules. Intramolecular aryl to ketone singlet energy transfer in the trans- and cis-decalins, 7-keto-13.beta.-methyl-5,6,7,8,9,10,13.beta.,14.alpha.-octahydrophenanthrene, and its 14.beta. isomer. The Journal of Organic Chemistry. 51(24). 4676–4681. 12 indexed citations

20.

Morrison, Harry, Tej Vir Singh, & Brad D. Maxwell. (1986). Organic photochemistry. 64. Aryl-activated carbon-chlorine bond cleavage at the bridgehead positions in 1-chloro- and 1,4-dichloro-7,7-dimethoxybenzonorbornene. The Journal of Organic Chemistry. 51(19). 3707–3708.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact